title: Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia.
abstract: OBJECTIVE
  To study the effects of low doses of the hormone atrial natriuretic peptide (ANP) on uteroplacental blood flow in patients with preeclampsia.
  
  
  METHODS
  Eleven women with preeclampsia were infused intravenously with ANP (10 ng/kg/minute). Uteroplacental blood flow index was measured using dynamic placental scintigraphy with indium-113m. Regional blood flows were assessed by pulsed Doppler ultrasound and expressed as pulsatility index (PI). Hemodynamic measurements and blood sampling for peripheral venous plasma analysis of cyclic guanosine monophosphate (cGMP), an ANP second messenger, were performed before and after 30 minutes of infusion. Nonparametric statistics were used.
  
  
  RESULTS
  The uteroplacental blood flow index increased by 28% (-2 to 58%; mean and 95% confidence interval). The Doppler findings were unaffected. Mean arterial blood pressure decreased from 112 (108-117) to 108 (103-114) mmHg (P < .01). Cyclic GMP increased significantly from 9.2 (6.2-12.3) to 17.4 (12.3-22.6) nmol/L (P < .01). Subjects exhibiting a substantial increase in uteroplacental blood flow index (25% or more) demonstrated a significantly greater cGMP response (P < .01) than those who did not (6% or less increase).
  
  
  CONCLUSIONS
  A tendency to an increased uteroplacental blood flow index combined with minor blood pressure reduction after ANP infusion suggest the possibility of uteroplacental vasodilatation.
authors.affiliation: Department of Obstetrics and Gynecology, Huddinge University Hospital, Sweden.
authors.forename: C
authors.initials: C
authors.lastname: Grunewald
authors.forename: H
authors.initials: H
authors.lastname: Nisell
authors.forename: T
authors.initials: T
authors.lastname: Jansson
authors.forename: M
authors.initials: M
authors.lastname: Kublickas
authors.forename: S
authors.initials: S
authors.lastname: Thornström
authors.forename: L
authors.initials: L
authors.lastname: Nylund
mesh_terms: D000328:Adult; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage*; D001783:Blood Flow Velocity / Q000187:drug effects* / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D005260:Female; D006157:Guanosine Monophosphate / Q000097:blood; D006801:Humans; D007205:Indium Radioisotopes; D007262:Infusions, Intravenous; D008431:Maternal-Fetal Exchange / Q000187:drug effects* / Q000502:physiology; D010920:Placenta / Q000098:blood supply / Q000000981:diagnostic imaging; D011225:Pre-Eclampsia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D011247:Pregnancy; D011673:Pulsatile Flow; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology; D016216:Ultrasonography, Prenatal; D014599:Uterus / Q000098:blood supply / Q000000981:diagnostic imaging; D014664:Vasodilation / Q000187:drug effects* / Q000502:physiology
chemical_list: D007205:Indium Radioisotopes; D006157:Guanosine Monophosphate; D009320:Atrial Natriuretic Factor